A controversial subject in the realm of health, fenbendazole, and cancer, is fast returning as a hot topic. Fenbendazole, often known as "fenben," is a parasiticide that kills parasites by disrupting their microtubules, causing the worms to starve to death. Cancer sufferers are hopeful that fenben will be able to destroy cancer cells in the same manner.

According to one research, "repurposing of veterinary medications with promising outcomes for human use may result in a significant decrease in the time and costs necessary to produce new treatments."

Human studies have shown that fenben seems to be well tolerated by people, with no reports of serious adverse effects being reported thus far. Even though it is not conclusively proven, research indicates that fenben is safe for people.

The findings of another research found that "doses up to 500 mg per individual were not associated with deleterious effects." It goes on to say that "single dosages up to 2,000 mg per individual were observed to generate no harmful effects," according to the research.

Dog de-wormer for cancer has been used to treat prostate, colon, colorectal, pancreatic, and non-small cell lung tumors in patients who had previously failed to do so.

Remember that Mebendazole, rather than Fenbendazole, has been studied in the treatment of cancer in people. This is vital to remember. While both are meant to eradicate parasites, Mebendazole is specifically developed to be used on people. Fenbendazole, on the other hand, seems to be the more successful medicine in the treatment of cancer in people, according to a study.

Several medications that are often used to treat non-cancerous disorders have shown promise in the treatment of cancer. New cancer therapies may be studied and provided swiftly at a lesser cost as a result of the repurposing of existing medications, hence satisfying the demands of patients.

Other than Joe Tippens' success story, several other success stories have arisen, offering more evidence that fenben is a successful cancer treatment.

The following three success stories are detailed in Clinical Oncology Case Reports, Volume 2021:

Arrived in his doctor with flank (back) discomfort, fast weight loss, and a fever, a 63-year-old Caucasian guy presented with a fever and flank (back) pain. An abdomen CT scan showed a solid left lower-pole renal tumor measuring 3 cm in diameter. He had surgery, and analysis revealed that he had a high-grade clear cell Renal Cell Carcinoma, which was removed (RCC). Following this, he began experiencing more severe left flank discomfort, and scans revealed a new left kidney mass measuring 5.2 cm in circumference. 

Chemotherapy treatment was initiated by the oncologist. The results of a follow-up CT scan a few weeks later showed a new mass in the pancreas. A fresh lesion was discovered on his pelvis a short time later. Doctors decided to stop his chemotherapy since the adverse effects were becoming overwhelming. Fenbendazole was recommended to him by a buddy who had been diagnosed with head and neck cancer. Following the administration of Fenbendazole, MRI scans revealed that his renal mass had almost disappeared and that the size of his pancreatic and pelvic masses had decreased. Imaging was performed ten months later and indicated no evidence of recurrence or metastatic illness. He has continued to use Fenbendazole without experiencing any negative side effects.

Case #2 A 72-year-old Caucasian guy arrived at the emergency department with worsening lower urinary tract symptoms and a urethral lesion. He was admitted to the hospital. Following his operation, he developed a cough four years later. Lung cancer with swollen lymph nodes was discovered on scans, and a head CT indicated a brain tumor that had spread to the brain. After receiving chemotherapy, the patient showed signs of being almost completely recovered. The patient, on the other hand, acquired a malignant lesion of his aorta and chose Fenbendazole treatment, which included taking one gram orally three times per week, vitamin E 800 mg daily, curcumin 600 mg daily, and CBD oil, among other things. Serial CT scans taken over the previous nine months revealed a considerable reduction in size as well as a full radiographic response.

Case No. 3

Increased urinary tract symptoms and blood in her urine were seen in a 63-year-old Caucasian girl who reported these symptoms. A big bladder mass was discovered using CT imaging. She received chemotherapy as well as Fenbendazole at a dose of one gram three times weekly in addition to the chemotherapy. A follow-up CT scan revealed no indication of illness, and she was placed on observation while more testing was performed.

It has been shown in these three situations that Fenbendazole may be safely repurposed for the treatment of cancer in humans. Taking Fenbendazole, the dog de-wormer, for cancer has shown to have significant advantages, and there is little dispute about that.

Cancer patients treated with Fenbendazole have their share of doubters, and as with every new cancer therapy, the drug's usage is closely investigated before being approved for use. For others, the results of a dog de-wormer that can cure cancer seem too wonderful to be true, and they dismiss the findings as unfounded. They are skeptical that a simple de-wormer will be effective in the face of several other possible remedies failing.

It is critical to remember that research is still in its infancy phases while discussing this topic. It is yet uncertain which tumors will be able to be properly treated with Fenbendazole in the future. However, according to a new article published in Nature, Fenbendazole is relevant and has the potential to treat a wide range of cancers in the future.

To fully realize the enormous potential of medication repurposing for patients, innovative policy measures in the present medical regulatory framework are required.